Compare INO & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INO | RMAX |
|---|---|---|
| Founded | 1979 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 121.3M |
| IPO Year | 1999 | 2013 |
| Metric | INO | RMAX |
|---|---|---|
| Price | $1.55 | $6.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | ★ 647.3K | 217.6K |
| Earning Date | 03-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ 0.60 |
| Revenue | $42,220,086.00 | ★ $195,929,000.00 |
| Revenue This Year | $24,407.60 | $2.62 |
| Revenue Next Year | $331.40 | $1.24 |
| P/E Ratio | ★ N/A | $10.08 |
| Revenue Growth | ★ 19.37 | 11.13 |
| 52 Week Low | $1.30 | $5.66 |
| 52 Week High | $2.86 | $10.32 |
| Indicator | INO | RMAX |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 45.09 |
| Support Level | $1.48 | $5.66 |
| Resistance Level | $1.60 | $8.47 |
| Average True Range (ATR) | 0.07 | 0.27 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 6.25 | 71.09 |
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.